Recent evidence has highlighted lysophosphatidylinositol as the endogenous ligand to novel endocannabinoid receptor GPR55, making it a strong contender as the sixth endocannabinoid.
LPI, LysoPI, Lysophosphatidylinositol acid, Lyso-phosphatidylinositol, LPI lipid
